Importantly, a recent study showed frequent positivity for N-cadherin in ependymoma and identified increased N-cadherin levels as a predictor of earlier tumor recurrence, arguing a contrary role for N-cadherin as a marker of worse prognosis in ependymoma [129]. Here, CDH2 is linked to ependymoma.